Table 1.

Summary of main results in selected review publications.

Publication Domain	Author, Year	Article Type (Case Report /Study)	Summary
Clinical	Grayson P. C. et al., 2012, 2022 [2,7] Acha M. R et al., 2007 [11]	Study Study	Coronary artery involvement is common in TA Types of involvement: occlusion or stenosis of the coronary ostia and the proximal segments (type 1), focal or diffuse coronary arteritis (type 2) and coronary aneurysms (type 3)
	Sun T. et al., 2013 [29]	Study	The most frequent sites involved are the coronary ostium and the proximal segment of the coronary arteries
	Yang Y. et al., 2017 [31]	Study	Males tend to have more severe coronary stenosis and a higher risk for long-term mortality
	Cobilinschi C. et al., 2021 [27]	Case report	Coronary involvement is linked the atherogenic profile of patients
	Xu Y. et al., 2023 [28]	Study	The percentage of coronary lesions is pediatric TA is significantly higher than in the adult population
	Park J.S. et al., 2009 [12] Yokota K. et al., 2012 [13] Soni M. R. et al., 2012 [14] Lee H.K. et al., 2011 [15] Zhou S. et al., 2021 [16] Zhang T. et al., 2019 [17] Mihailovici A.R et al., 2018 [18]	Case report Case report Case report Case report Case report Case report Case report	Common symptoms in TA with coronary involvement: angina pectoris, dyspnea on exertion, retrosternal chest pain as acute myocardial infarction
Biological	Wang X. et al., 2016 [19]	Study	HsCRP can predict adverse cardiovascular events in TA with coronary artery involvement
	Saadoun D. et al., 2012 [20] Wang H. et al., 2020 [32]	Study Study	Biological inflammation at revascularization increases the risk of vascular complications with reinterventions Disease activity predicts progression in patients with TA and coronary stenosis
	O’Connor T.E. et al., 2014 [33]	Study	Inflammatory markers are not reliable to distinguish active from inactive disease
Drug therapy	Huang Z. et al., 2021 [21]	Study	Corticosteroids are used in combination with immunosuppressants, preferably before revascularization
Surgical therapy	Kuijer A. et al., 2015 [22] Wang X et al., 2015 [23] Wang X et al., 2017 [24]	Case report Study Study	Revascularization techniques for coronary stenosis are PCI, PCI with drug-eluting stents and CABG Coronary angioplasty and drug-eluting stent insertion have a high risk of restenosis PCI is an alternative to CABG after patients reach remission of the disease with medical therapy
	Yuan S. M., 2020 [25] Al-Hulaimi N. et al., 2001 [26]	Study Case report	Restenosis may occur even in the absence of clinical symptoms
	Ci W. et al., 2022 [30] Pathadan A.P et al., 2021 [34]	Study Study	Determining interleukin levels can be of use when initiating biological therapy